Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
1.200
-0.010 (-0.83%)
Apr 28, 2026, 3:08 PM EDT - Market open
Phio Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
6
Market Cap
13.94M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | 21.00K | -117.00K | -84.78% |
| Dec 31, 2018 | 138.00K | 123.00K | 820.00% |
| Dec 31, 2017 | 15.00K | -4.00K | -21.05% |
| Dec 31, 2016 | 19.00K | -15.00K | -44.12% |
| Dec 31, 2015 | 34.00K | -37.00K | -52.11% |
| Dec 31, 2014 | 71.00K | -328.00K | -82.21% |
| Dec 31, 2013 | 399.00K | 302.00K | 311.34% |
| Dec 31, 2012 | 97.00K | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cyclerion Therapeutics | 2.07M |
| Vyome Holdings | 319.71K |
| Jupiter Neurosciences | 21.80K |
| BioCardia | 3.00K |
| Soligenix | 2.34K |
PHIO News
- 13 days ago - Phio Pharmaceuticals Transcript: Fireside chat - Transcripts
- 14 days ago - Phio Pharmaceuticals Transcript: Second Annual Centri Capital Conference - Transcripts
- 15 days ago - Phio Pharmaceuticals Announces "Nobel Prize Winning Science Takes on Skin Cancer" in a Fireside Chat with Force Family Office on Wednesday, April 15, 2026 - Newsfile Corp
- 4 weeks ago - Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762 - Newsfile Corp
- 5 weeks ago - Phio Pharmaceuticals Announces American Academy of Dermatology 2026 Presentation Featuring Clinical Study Results from Study of PH-762 for Cutaneous Carcinoma Underscoring Clinical Pipeline Advancement - Newsfile Corp
- 6 weeks ago - Phio Pharmaceuticals Announces "A Groundbreaking Approach to Treating Skin Cancer" in a Fireside Chat with Force Family Office - Newsfile Corp
- 6 weeks ago - Phio Pharmaceuticals Transcript: Life Sciences Virtual Investor Forum - Transcripts
- 7 weeks ago - Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026 11 AM EDT - GlobeNewsWire